Mostrar el registro sencillo del ítem

dc.contributor.authorNuñez, Rafael
dc.contributor.authorFernández-Santamaría, Rubén
dc.contributor.authorSalas, María
dc.contributor.authorBogas, Gador
dc.contributor.authorDiez-Echave, Patricia
dc.contributor.authorMayorga Mayorga, Cristobalina
dc.contributor.authorTorres-Jaén, María Josefa 
dc.contributor.authorFernández-Duarte, Tahía Diana 
dc.date.accessioned2024-07-08T10:23:05Z
dc.date.available2024-07-08T10:23:05Z
dc.date.issued2024-06-29
dc.identifier.citationNuñez, R., Fernandez-Santamaria, R., Salas, M., Bogas, G., Diez-Echave, P., Mayorga, C., Torres, M.J. and Fernandez, T.D. (2024), Genomic variants association with selective hypersensitivity reactions to amoxicillin and clavulanic acid. Allergy.es_ES
dc.identifier.urihttps://hdl.handle.net/10630/31960
dc.description.abstractIn summary, there are rare variants found in our patients that could be related to the development of AX or CLV- induced IDHRs. Interestingly, some of these rare variants could be associated with selective response to AX, such as the proapoptotic endonuclease ENDOG and neutrophil degranulation pathway, previously associ- ated with drug- induced anaphylaxis,6 or to CLV, like immunoprote- asome component PSMD8. Differences could be related to nature and metabolic characteristics of each drug; however, more research is needed. These findings represent a first step to identify potential genetic biomarkers to predict the susceptibility of suffering AX and CLV IDHRs.es_ES
dc.description.sponsorshipThis work has been supported by Institute of Health ‘Carlos III’ (ISCIII) of the Ministry of Economy and Competitiveness (MINECO), (grants co- funded by European Regional Development Fund: PI15/01206, PI17/01237, PI18/00095, PI20/01734, PI21/0329, RETICS ARADYAL RD16/0006/0001, RICORS REI, RD21/0002/0008); Andalusian Regional Ministry of Health (grants PI- 0241- 2016, PE- 0172- 2018, PI- 0127- 2020). GB is a Clinical Investigator (B- 0007- 2022) re- search contract by Andalusian Regional Ministry Health. PDE holds a Sara Borrell research contract by Institute of Health ‘Carlos III’ (CD22/00112). CM holds a ‘Nicolas Monardes’ research contract by Andalusian Regional Ministry Health (RC- 0004- 2021). Funding for open access charge: Univesidad de Malaga/CBUA.es_ES
dc.language.isoenges_ES
dc.publisherWiley
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAlergiaes_ES
dc.subject.otherGenomic variantses_ES
dc.subject.otherHypersensitivity reactionses_ES
dc.subject.otherAmoxicillines_ES
dc.subject.otherClavulanic acides_ES
dc.titleGenomic variants association with selective hypersensitivityreactions to amoxicillin and clavulanic acides_ES
dc.typejournal articlees_ES
dc.centroFacultad de Medicinaes_ES
dc.identifier.doihttps://doi.org/10.1111/all.16229
dc.type.hasVersionVoRes_ES
dc.departamentoMedicina y Dermatología
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem